Skip to search boxSkip to navigationSkip to main content

Synthetic triterpenoid CDDO prevents the progression and metastasis of prostate cancer in TRAMP mice by inhibiting survival signaling

  • Dorrah Deeb
    ,
  • Xiaohua Gao
    ,
  • Yongbo Liu
    ,
  • Daniel Jiang
    ,
  • George W. Divine
    ,
*Corresponding author for this work
  • Henry Ford Health System
Scholary Output:
Contribution to journal
Article
Research
Peer-review

Open access

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

In an extension of our previous studies showing potent antitumorigenic activity of synthetic triterpenoids of oleanolic acid against prostate cancer cell lines, we examined the efficacy of 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid (CDDO) in preventing the development and/or progression of prostate cancer in the transgenic adenocarcinoma of the mouse prostate (TRAMP) model. Data show that oral gavage with CDDO (10 μmol/kg) for 20 weeks resulted in inhibition of the progression of preneoplastic lesions in the dorsolateral prostate and ventral prostate to adenocarcinoma without toxicity. CDDO also inhibited metastasis of tumor to the distant organs. Treatment with CDDO significantly inhibited cell proliferation, reduced the density of blood vessels and promoted apoptosis in the prostatic tissue. Further, Akt, NF-κB and NF-κB regulated Bcl-2, Bcl-xL, survivin and cIAP1 appear to be the molecular targets of CDDO for inhibiting the progression of prostate cancer in TRAMP mice. Thus, these studies show for the first time the potential of CDDO for chemoprevention of human prostate cancer.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Research
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 757-764 (8 pages)

Journal (Volume, Issue Number)

Carcinogenesis (Volume 32, Issue 5)

Publication milestones

  • Published - 05/2011

Publication status

Published - 05/2011

ISSN

0143-3334

Publication IDs

  • Scopus: 79955754337
  • PubMed: 21325633

Publication metrics

Metrics

SciVal
citations
30
Fractional count
1
Fractional count
0.13
Fractional count
7
Fractional count
0.88
Fractional count
1
Fractional count
1
Scopus
citations
SciVal
FWCI
1.25
SciVal
Author count
8
SciVal
Paper percentile
84

PlumX, opens in new tab

Mentions
1
Citation count
32
Captures
26

Funding Details

National Institutes of Health grants (CA130948 to S.C.G., CA122031 to A.S.A.).
FundersFunding numbers
NIH
CA122031
NCI
R01CA130948